Log in to save to my catalogue

Design and evaluation of novel barrier layer technologies for controlling venlafaxine hydrochloride...

Design and evaluation of novel barrier layer technologies for controlling venlafaxine hydrochloride...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_24754412

Design and evaluation of novel barrier layer technologies for controlling venlafaxine hydrochloride release from tablet dosage form

About this item

Full title

Design and evaluation of novel barrier layer technologies for controlling venlafaxine hydrochloride release from tablet dosage form

Publisher

England: Informa Healthcare

Journal title

Pharmaceutical development and technology, 2015-01, Vol.20 (5), p.588-597

Language

English

Formats

Publication information

Publisher

England: Informa Healthcare

More information

Scope and Contents

Contents

Context: Venlafaxine Hydrochloride (VH) is a highly soluble and highly permeable antidepressant compound. Thus controlling VH release from tablet dosage form over a prolonged period is a challenge.
Objective: The objective of this work was to study the effect of various barrier layer formulation compositions, its orientations and manufacturing t...

Alternative Titles

Full title

Design and evaluation of novel barrier layer technologies for controlling venlafaxine hydrochloride release from tablet dosage form

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_24754412

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_24754412

Other Identifiers

ISSN

1083-7450

E-ISSN

1097-9867

DOI

10.3109/10837450.2014.908303

How to access this item